StonvexLoading…
StonvexStonvexStonvexCore line items from RNTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-50.63M | $-65.11M | $-16.28M | $-27.65M |
Net Income | $-49.87M | $-62.88M | $-15.73M | $-27.33M |
EPS (Diluted) | $-1.96 | $-3.51 | $-3.42 | $-6.02 |
Total Assets | $24.16M | $62.19M | $106.01M | $22.01M |
Total Liabilities | $7.24M | $7.80M | $7.71M | $3.38M |
Cash & Equivalents | $3.21M | $12.87M | $17.34M | $5.19M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 27.55M | 21.67M | 4.89M | 4.54M |